190 related articles for article (PubMed ID: 1264980)
1. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].
Fokina LV; Vusygina RN; Antosik OD
Probl Tuberk; 1976 Feb; (21):34-9. PubMed ID: 1264980
[No Abstract] [Full Text] [Related]
2. Side effects of rifampicin. A clinical study.
Mattson K
Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
[No Abstract] [Full Text] [Related]
3. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
[No Abstract] [Full Text] [Related]
4. [Study of adverse reactions in pulmonary tuberculosis patients treated with rifampicin].
Anastasatu C; Dinulică E; Algeorge G; Cărpinişan L; Varga E; Rudescu D
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):213-9. PubMed ID: 174177
[TBL] [Abstract][Full Text] [Related]
5. Hepatorenal failure with self-initiated intermittent rifampicin therapy.
Rothwell DL; Richmond DE
Br Med J; 1974 Jun; 2(5917):481-2. PubMed ID: 4834100
[No Abstract] [Full Text] [Related]
6. [The optimal use of rifampicin in the polychemotherapy of pulmonary tuberculosis, with special reference to its liver-damaging potential: considerations and case studies].
Salvati F; Mugnaini L; Altieri AM; De Marinis F
Clin Ter; 1979 Jan; 88(1):45-50. PubMed ID: 436377
[No Abstract] [Full Text] [Related]
7. Acute renal failure during intermittent rifampicin therapy.
Campese VM; Marzullo F; Schena FP; Coratelli P
Nephron; 1973; 10(4):256-61. PubMed ID: 4573698
[No Abstract] [Full Text] [Related]
8. Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.
Wäre M; Heinivaara O; Elo R; Tala E
Scand J Respir Dis Suppl; 1969; 69():59-63. PubMed ID: 4906375
[No Abstract] [Full Text] [Related]
9. A case of rifampicin-induced haemolysis.
Sykes CA; Shepherd J; McGoldrick C; Kennedy N; Raafat A
Int J Tuberc Lung Dis; 2019 Feb; 23(2):239-240. PubMed ID: 30808458
[TBL] [Abstract][Full Text] [Related]
10. [Use of rifampicin in tuberculous patients with liver diseases].
Pozzi E; Menghini P
G Ital Chemioter; 1972 Jul; 19(3):63-8. PubMed ID: 4671348
[No Abstract] [Full Text] [Related]
11. [Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
Macquet V; Lafitte P; Rogeaux Y
Lille Med; 1972 May; 17(5):755-61. PubMed ID: 5056293
[No Abstract] [Full Text] [Related]
12. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
Chioléro R
Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
[No Abstract] [Full Text] [Related]
13. Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication.
Manika K; Tasiopoulou K; Vlogiaris L; Lada M; Papaemmanouil S; Zarogoulidis K; Kioumis I
Ren Fail; 2013 Sep; 35(8):1179-81. PubMed ID: 23883374
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
[No Abstract] [Full Text] [Related]
15. Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case.
Juang YC; Tsao TC; Chiang YC; Lin JL; Tsai YH
J Formos Med Assoc; 1992 Apr; 91(4):475-6. PubMed ID: 1358323
[TBL] [Abstract][Full Text] [Related]
16. [Recurrent renal failures in continuous treatment with rifampicin].
Löllgen H; Bolte JP
Munch Med Wochenschr; 1973 May; 115(20):913-5. PubMed ID: 4740450
[No Abstract] [Full Text] [Related]
17. [Use of rifampicin in tuberculosis].
Rabukhin AE
Klin Med (Mosk); 1973 Mar; 51(3):70-6. PubMed ID: 4755485
[No Abstract] [Full Text] [Related]
18. [Severe complications following intermittent administration of rifampicin].
Manasia M; Paul G; Maniţiu PI
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(3):183-8. PubMed ID: 188103
[TBL] [Abstract][Full Text] [Related]
19. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
Kuntz HD; Rausch V; Bammel E
Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
[No Abstract] [Full Text] [Related]
20. [Complications with rifampicin treatment: one case with anuria (author's transl)].
Chevalier JP; Plantier J; Kofman J; Montagnon B; Magnin F; Perrin-Fayolle M; Traeger J
Poumon Coeur; 1980; 36(4):287-91. PubMed ID: 7443620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
